Jeremy M. Levin

Insider Reports History

Signature: /s/ Jason Minio, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeremy M. Levin:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Ovid Therapeutics Inc.	CEO, Director	Common Stock	3.62M	$9.98M	$2.76	Mar 18, 2024	Direct
Ovid Therapeutics Inc.	CEO, Director	Common Stock	35.5K	$97.9K	$2.76	Mar 18, 2024	Indirect
Ovid Therapeutics Inc.	CEO, Director	Employee Stock Option (Right to Buy)	1.65M			Feb 20, 2025	Direct
Ovid Therapeutics Inc.	CEO, Director	Stock Option (Right to Buy)	700K			Feb 22, 2024	Direct

Showing 1 to 4 of 4 entries

Insider Reports Filed by Jeremy M. Levin

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
OVID	Ovid Therapeutics Inc.	Feb 20, 2025	1	$0	4	Feb 24, 2025	CEO, Director
OVID	Ovid Therapeutics Inc.	Mar 18, 2024	1	$50.4K	4	Mar 20, 2024	CEO, Director
OVID	Ovid Therapeutics Inc.	Feb 22, 2024	1	$0	4	Feb 26, 2024	CEO, Director
OVID	Ovid Therapeutics Inc.	Dec 4, 2023	2	$0	4	Dec 6, 2023	CEO, Director
OVID	Ovid Therapeutics Inc.	Feb 23, 2023	1	$0	4	Feb 27, 2023	CEO, Director, 10%+ Owner
OVID	Ovid Therapeutics Inc.	Apr 8, 2022	1	$0	4	Apr 12, 2022	CEO, Director, 10%+ Owner
OVID	Ovid Therapeutics Inc.	Feb 3, 2022	1	$0	4	Feb 4, 2022	CEO, Director, 10%+ Owner
OVID	Ovid Therapeutics Inc.	Oct 8, 2019	1	$0	4/A	Feb 14, 2024	CEO, Director